NO and prostanoids blunt endothelin-mediated coronary vasoconstrictor influence in exercising swine

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 5, 2006, Pages

  Merkus, Daphne ^a   Sorop, Oana ^a   Houweling, Birgit ^a   Boomsma, Frans ^b   Van Den Meiracker, Anton H ^b   Duncker, Dirk J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Coronary blood flow; Coronary circulation; Exercise; Myocardial oxygen balance

Indexed keywords

ENDOTHELIN; INDOMETACIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTANOID; TEZOSENTAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; EXERCISE; FEMALE; HEART RATE; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; CARDIAC OUTPUT; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; ENDOTHELINS; EXERTION; FEMALE; HEART RATE; INDOMETHACIN; MALE; NITRIC OXIDE; NITROARGININE; OXYGEN CONSUMPTION; PHYSICAL CONDITIONING, ANIMAL; PROSTAGLANDINS; PYRIDINES; RECEPTORS, ENDOTHELIN; SUS SCROFA; TETRAZOLES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 33751171554     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01109.2005     Document Type: Article

References (37)

1. Altman JD, Kinn J, Duncker DJ, and Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res 28: 119-124, 1994.
2. Boulanger C and Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587-590, 1990.
3. Climent B, Fernandez N, Sanz E, Sanchez A, Monge L, Garcia-Villalon AL, and Dieguez G. Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids. Eur J Pharmacol 524: 102-110, 2005.
4. Dai XZ and Bache RJ. Effect of indomethacin on coronary blood flow during graded treadmill exercise in the dog. Am J Physiol Heart Circ Physiol 247: H452-H458, 1984.
5. Duffy SJ, Castle SF, Harper RW, and Meredith IT. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation 100: 1951-1957, 1999.
6. Duncker DJ and Bache RJ. Regulation of coronary vasomotor tone under normal conditions and during acute myocardial hypoperfusion. Pharmacol Ther 86: 87-110, 2000.
7. 2-consumption in exercising swine. Cardiovasc Res 47: 738-748, 2000.
8. Duncker DJ, Stubenitsky R, and Verdouw PD. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward beta-adrenergic control. Circ Res 82: 1312-1322, 1998.
9. Feigl EO. Coronary physiology. Physiol Rev 63: 1-205, 1983.
10. Houweling B, Merkus D, Dekker MM, and Duncker DJ. Nitric oxide blunts the endothelin-mediated pulmonary vasoconstriction in exercising swine. J Physiol 568: 629-638, 2005.
11. + channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 82: 346-359, 1998.
12. Kelly LK, Wedgwood S, Steinhorn RH, and Black SM. Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am J Physiol Lung Cell Mol Physiol 286: L984-L991, 2004.
13. Kjekshus H, Smiseth OA, Klinge R, Oie E, Hystad ME, and Attramadal H. Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF. Am J Physiol Heart Circ Physiol 278: H1299-H1310, 2000.
14. Koller A, Sun D, Huang A, and Kaley G. Corelease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arterioles. Am J Physiol Heart Circ Physiol 267: H326-H332, 1994.
15. Laughlin MH, Korthuis R, Duncker DJ, and Bache RJ. Control of blood flow to cardiac and skeletal muscle during exercise. In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda MD: Am. Physiol. Soc., 1996, sect. 12, chapt. 16, p. 705-769.
16. Lavallee M and Thorin E. Role of ET-1 in the regulation of coronary circulation. Can J Physiol Pharmacol 81: 570-577, 2003.
17. Luscher TF and Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102: 2434-2440, 2000.
18. McEniery CM, Wilkinson IB, Jenkins DG, and Webb DJ. Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension 40: 202-206, 2002.
19. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, and Morton JJ. Plasma endothelin in chronic heart failure. Circulation 85: 1374-1379, 1992.
20. Merkus D, Duncker DJ, and Chilian WM. Metabolic regulation of coronary vascular tone: role of endothelin-1. Am J Physiol Heart Circ Physiol 283: H1915-H1921, 2002.
21. Merkus D, Houweling B, Mirza A, Boomsma F, van den Meiracker AH, and Duncker DJ. Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 59: 745-754, 2003.
22. Merkus D, Houweling B, Zarbanoui A, and Duncker DJ. Interaction between prostanoids and nitric oxide in regulation of systemic, pulmonary, and coronary vascular tone in exercising swine. Am J Physiol Heart Circ Physiol 286: H1114-H1123, 2004.
23. Merkus D, Stepp DW, Jones DW, Nishikawa Y, and Chilian WM. Adenosine preconditions against endothelin-induced constriction of coronary arterioles. Am J Physiol Heart Circ Physiol 279: H2593-H2597, 2000.
24. Nambi P, Clozel M, and Feuerstein G. Endothelin and heart failure. Heart Fail Rev 6: 335-340, 2001.
25. Omland T, Lie RT, Aakvaag A, Aarsland T, and Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89: 1573-1579, 1994.
26. Osanai T, Fujita N, Fujiwara N, Nakano T, Takahashi K, Guan W, and Okumura K. Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol Heart Circ Physiol 278: H233-H238, 2000.
27. Pacold I, Hwang MH, Lawless CE, Diamond P, Scanlon PJ, and Loeb HS. Effects of indomethacin on coronary hemodynamics, myocardial metabolism and anginal threshold in coronary artery disease. Am J Cardiol 57: 912-915, 1986.
28. 2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 269: 11938-11944, 1994.
29. 2 inhibit ET-1 secretion from endothelial cells by stimulating particulate guanylate cyclase. Am J Physiol Heart Circ Physiol 270: H1342-H1349, 1996.
30. Schiffrin EL and Touyz RM. Vascular biology of endothelin. J Cardiovasc Pharmacol 32: S2-S13, 1998.
31. Selvais PL, Robert A, Ahn S, van Linden F, Ketelslegers JM, Pouleur H, and Rousseau MF. Direct comparison between endothelin-1, Nterminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail 6: 201-207, 2000.
32. Stepp DW, Merkus D, Nishikawa Y, and Chilian WM. Nitric oxide limits coronary vasoconstriction by a shear stress-dependent mechanism. Am J Physiol Heart Circ Physiol 281: H796-H803, 2001.
33. Tune JD, Richmond KN, Gorman MW, and Feigl EO. Control of coronary blood flow during exercise. Exp Biol Med (Maywood) 227: 238-250, 2002.
34. + channels, nitric oxide, and adenosine are not required for local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol 280: H868-H875, 2001.
35. Tune JD, Richmond KN, Gorman MW, and Feigl EO. Role of nitric oxide and adenosine in control of coronary blood flow in exercising dogs. Circulation 101: 2942-2948, 2000.
36. Wiley KE and Davenport AP. Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol 132: 213-220, 2001.
37. Wiley KE and Davenport AP. Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery. Br J Pharmacol 133: 568-574, 2001.